Open-house discount agreements for dorzolamide 2026-11 (ATR, EDO)

Summary

The procurement concerns discount agreements for medicines containing dorzolamide (ATR, EDO), to be concluded with the health insurance funds HEK and/or hkk according to the relevant lot. Unless the agreement provides otherwise, it covers all interchangeable finished medicinal products supplied by the contracting partner. This is an open-house procedure with uniform terms for all participants and no exclusivity; participation is possible throughout the contract period.